Featured Article
Precision Oncology Today
Magazine
Fully Exposed: Understanding the Exposome Can Drive the Future of Health and Wellness
The field of exposomics is still in its early stages. Pioneering researchers are grappling with methods to marry multi-omic datasets, blood and urine mass spectrometry data, and even postal code and satellite data to gain insights into the highly complex interface between human biology and environmental exposures--and how it affects human health and wellness.
In Conversation with Michelle Werner
Inside Precision Medicine’s editor in chief, Damian Doherty, spoke to Werner, Alltrna's CEO, about her career, her motivation to lead this company, and what rare disease means to her on a personal level.
Trending on Inside Precision Medicine
Enzyme Identified That Saps T Cells’ Ability to Attack Solid Tumors
Researchers at the UNC Lineberger Comprehensive Cancer Center have identified an enzyme that saps the energy of T cells once they have infiltrated a solid tumor and prevents them from effectively combatting cancer.
Wireless Sensor Could Help Crohn’s Patients Get Faster Treatment
A specially designed wireless sensor is effective at detecting Crohn's disease flareups in model mice over a month before lesions appear.
NVIDIA and DCVC Fund Relation for Osteoporosis Drug Discovery
AI firm Relation Tx has raised $35 million in a round led by DCVC and co-led by NVIDIA's venture, NVentures.